ERBI unveils new name and brand identity: One Nucleus
ERBI, the not-for-profit membership company for international life science and healthcare businesses, unveiled its new name and brand identity – One Nucleus – at the opening of its 12th annual Conference at the Wellcome Trust Sanger Institute, Cambridge, UK.
One Nucleus is a new name for a new era, representing one network for biotech, pharma, medical device and diagnostic businesses. One Nucleus also speaks to the unification of the Cambridge and London Networks, following ERBI’s merger with the London Biotechnology Network (LBN).
One Nucleus CEO, Harriet Fear, commented: “One Nucleus is the business catalyst for life sciences. We’d outgrown ERBI and needed a new name to match our reality as a global force in life science and healthcare. We intend to use this new identity as a springboard to new and improved benefits for members, building on the combined strength of our Cambridge and London membership.”
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Atomic insights into plant growth - Researchers from Tübingen resolve how a plant steroid hormone makes plants grow
Changes in biotech regulations must not be an attempt to further delay the approvals process
Category:Transmembrane_proteins
Researcher invents lethal 'lint brush' to capture and kill cancer cells in the bloodstream
